for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ICON PLC

ICLR.O

Latest Trade

151.30USD

Change

0.64(+0.42%)

Volume

95,855

Today's Range

150.04

 - 

151.90

52 Week Range

118.10

 - 

165.14

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
150.66
Open
150.87
Volume
95,855
3M AVG Volume
4.81
Today's High
151.90
Today's Low
150.04
52 Week High
165.14
52 Week Low
118.10
Shares Out (MIL)
54.08
Market Cap (MIL)
8,135.60
Forward P/E
21.87
Dividend (Yield %)
--

Next Event

Q3 2019 ICON PLC Earnings Release

Latest Developments

More

Icon Plc Qtrly Earnings Per Share $1.63

MolecularMD Acquired By Icon

Icon Reports Third Quarter 2018 Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About ICON PLC

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

Industry

Biotechnology & Drugs

Contact Info

South County Business Park, Dublin 18

+353.1.2912000

http://www.iconplc.com/

Executive Leadership

Ciaran Murray

Chairman of the Board

Steve Cutler

Chief Executive Officer, Director

Brendan Brennan

Chief Financial Officer

Diarmaid Cunningham

Executive Vice President, General Counsel, Secretary

Hugh Brady

Non-Executive Director

Key Stats

1.86 mean rating - 14 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

1.7K

2017

1.8K

2018

2.6K

2019(E)

2.8K
EPS (USD)

2016

4.700

2017

5.390

2018

6.090

2019(E)

6.879
Price To Earnings (TTM)
23.23
Price To Sales (TTM)
3.01
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
19.21
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

BRIEF-Icon To Cut Administrative Costs And Raise Regulatory Compliance

* ICON LAUNCHES FIRECREST FINANCIAL DISCLOSURE TO REDUCE ADMINISTRATIVE COSTS AND INCREASE REGULATORY COMPLIANCE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-ICON Plc Reports Q1 Earnings Per Share Of $1.42

* EXCLUDING IMPACT OF ASC 606, CLOSING BACKLOG OF $5,053 MILLION AT QUARTER END , AN INCREASE OF 17.2% YEAR ON YEAR

BRIEF-ICON Announces Deal With Intel Allowing Integration Of The Intel Pharma Analytics Platform For Clinical Trials

* ICON ANNOUNCES AGREEMENT WITH INTEL ALLOWING INTEGRATION OF THE INTEL® PHARMA ANALYTICS PLATFORM FOR CLINICAL TRIALS

BRIEF-Icon PLC Reports Qtrly EPS Of $1.43​

* IN Q4 NET REVENUE GREW 4.6% YEAR ON YEAR TO $455 MILLION FROM $435 MILLION IN SAME QUARTER LAST YEAR

BRIEF-Icon Expects FY2018 Revenue In Range Of $1,870 Mln - $1,930 Mln

* - FULL YEAR 2018 REVENUE GUIDANCE IN RANGE OF $1,870 - $1,930 MILLION, REPRESENTING GROWTH OF 7 - 10%

BRIEF-Icon Plc Q3 EPS $1.35

* Qtrly net revenue increased 4.8% to $440 million compared to same quarter last year

BRIEF-Icon sees ‍2017 earnings per share $5.18-$5.38

* Qtrly net revenue increased 5.0% to $431 million; qtrly earnings per share $1.31

BRIEF-Icon acquires Mapi Group

* Icon Plc - has acquired Mapi Group Source text for Eikon: Further company coverage:

BRIEF-Icon reports Q4 earnings of $1.33 per share

* Q4 earnings per share view $1.26 -- Thomson Reuters I/B/E/S

BRIEF-Icon sees FY 2017 earnings per share $5.00 to $5.20

* Co confirmed its current guidance, of 2016 earnings in range of $4.60 - $4.80 and 2016 revenue in range of $1,665 - $1,680 million

BRIEF-Cynosure receives CFDA nod to market the Icon aesthetic system in China

* Cynosure receives CFDA clearance to market the Icon aesthetic system in China

BRIEF-Icon announces appointment of Ronan Murphy to board

* Icon announces appointment of Ronan Murphy to board of directors Source text for Eikon: Further company coverage:

BRIEF-ICON Q3 earnings per share $1.19 excluding items

* Q3 earnings per share view $1.18 -- Thomson Reuters I/B/E/S

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up